Objectives: At the end of this program, participants should be able to:
1. To introduce ex-RNAs as a new class of biomarkers for stroke
2. To demonstrate how next-generation sequencing technology can be cobined with clinical samples to provide new insight about complex disease.
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation